Literature DB >> 15601815

Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia.

Anne Marie Valente1, Rajiv Jain, Mark Scheurer, Vance G Fowler, G Ralph Corey, A Resai Bengur, Stephen Sanders, Jennifer S Li.   

Abstract

PURPOSE: The prevalence of infective endocarditis (IE) among children with Staphylococcus aureus bacteremia (SAB) is unknown. The objective of this study was to determine prospectively the prevalence of IE among pediatric patients with SAB in a large tertiary care center.
METHODS: Between July 1998 and June 2001, all children who developed SAB whose parent/guardian signed informed consent underwent echocardiography. Clinical and follow-up results were collected prospectively. Endocarditis was classified according to the modified Duke criteria.
RESULTS: Fifty-one children developed SAB during the study interval. Definite (6 patients [11.8%]) or possible (4 patients [7.8%]) IE was present in 10 of 51 (20%) children with SAB. Most children (73%) developed bacteremia as a consequence of an infected intravascular device. Children with underlying congenital heart disease had a significantly higher prevalence of definite or possible IE, compared with those with structurally normal hearts (53% vs 3%). All patients with definite IE had multiple positive blood cultures. Mortality was high among patients with and without IE (40% vs 12%).
CONCLUSIONS: In this study, the prevalence of definite IE among children with SAB was approximately 12% and was frequently associated with congenital heart disease and multiple positive blood cultures. The mortality for children with SAB and definite or possible S aureus IE is high.

Entities:  

Mesh:

Year:  2004        PMID: 15601815     DOI: 10.1542/peds.2004-1152

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia.

Authors:  Ganesh Kumarachandran; Jennifer Kristie Johnson; Debbie-Ann Shirley; Eileen Graffunder; Emily L Heil
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

2.  Bacterial pancarditis with myocardial abscess: successful surgical intervention in a 14-month-old boy.

Authors:  Jonathan K Yoon; M Babak Rahimi; Andrew Fiore; Kenneth Schowengerdt; Saadeh B Jureidini
Journal:  Tex Heart Inst J       Date:  2015-02-01

3.  Microbiological characteristics of community-associated Staphylococcus aureus causing uncomplicated bacteremia and infective endocarditis.

Authors:  Chia-Yu Chi; Shih-Min Wang; Chia-Chun Lin; Ching-Chuan Liu
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

4.  Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.

Authors:  Yong Pil Chong; Song Mi Moon; Kyung-Mi Bang; Hyun Jung Park; So-Youn Park; Mi-Na Kim; Ki-Ho Park; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jin-Yong Jeong; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

5.  Sepsis in young infants with congenital heart disease.

Authors:  S B Ascher; P B Smith; R H Clark; M Cohen-Wolkowiez; J S Li; K Watt; E Jacqz-Aigrain; F Kaguelidou; P Manzoni; D K Benjamin
Journal:  Early Hum Dev       Date:  2012-05       Impact factor: 2.079

Review 6.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Authors:  Kerry J Welsh; April N Abbott; Evan M Lewis; Jeanelle M Gardiner; Mark C Kruzel; Cole T Lewis; John F Mohr; Audrey Wanger; Lisa Y Armitige
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

8.  A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection.

Authors:  Alessander O Guimaraes; Yi Cao; Kyu Hong; Oleg Mayba; Melicent C Peck; Johnny Gutierrez; Felicia Ruffin; Montserrat Carrasco-Triguero; Jason B Dinoso; Angelo Clemenzi-Allen; Catherine A Koss; Stacey A Maskarinec; Henry F Chambers; Vance G Fowler; Amos Baruch; Carrie M Rosenberger
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

9.  The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.

Authors:  Clare Piper; Pat G Casey; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Int J Microbiol       Date:  2012-01-12

10.  Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period.

Authors:  J Le; Q Dam; T Tran; A Nguyen; F C Adler-Shohet; S Kim; K Schmidt; J M Lieberman; J S Bradley
Journal:  Epidemiol Infect       Date:  2017-07-27       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.